3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Diabetes Mellitus, Type 2
1
Cushing Syndrome
1
ACTH Syndrome, Ectopic
1
Interventions
relacorilant
1
Radiofrequency Ablation
1
Osilodrostat
1
ASP3662
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
ACTH Syndrome, Ectopic
×
ASP3662
×
90 days
×
Clear all
NCT07296484
2026-05-12
CAPTAIN-T2D
Sparrow Pharmaceuticals
Phase 2
Recruiting
1,500 enrolled